Literature DB >> 10479394

Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.

Y Sera1, E Kawasaki, N Abiru, M Ozaki, T Abe, H Takino, H Kondo, H Yamasaki, Y Yamaguchi, S Akazawa, S Nagataki, Y Uchigata, N Matsuura, K Eguchi.   

Abstract

It has been reported that there is a heterogeneity in the clinical course of Japanese patients with type 1 diabetes. To elucidate the associations of expression of autoantibodies to multiple islet antigens with age of onset and mode of diagnosis of diabetes in Japanese patients with type 1 diabetes, autoantibodies against the protein tyrosine phosphatase-like molecules ICA512 (IA-2) and phogrin (IA-2beta) (ICA512/phogrin-A), GAD (GADA), insulin (IAA), and islet cell cytoplasm (ICA) were determined in sera from 73 Japanese patients with type 1 diabetes obtained within 14 days of diagnosis. Patients were divided into groups based on the age of onset (</=10 years, n=24 and >10 years, n=49) or the mode of onset (abrupt onset, n=59 and urinary screening identified, n=14). Of 73 new-onset patients with type 1 diabetes, 43 (59%) and 32 (44%) had ICA512A and phogrin-A levels exceeding the 99th percentile of 184 normal control subjects, respectively. Forty-five patients (62%) were positive for either ICA512A or phogrin-A. The frequencies for other autoantibodies were 71% for GADA, 48% for IAA, and 62% for ICA. The frequency of ICA512/phogrin-A was significantly higher in patients with an age of onset less than 10 years (83%) than in patients aged >10 years (51%, P<0.01). The positivity of ICA512/phogrin-A was less in patients whose diabetes was diagnosed by the urine glucose screening test (21%, P<0.001) than in abrupt onset patients (71%). Combined analysis (>/=1 antibody) of GADA, IAA, and ICA512/phogrin-A detected 88% of abrupt onset and 93% of screening-positive patients vs. 70% and 29%, respectively, for ICA (P<0.0005). These results indicate that the expression of ICA512/phogrin-A and cytoplasmic ICA is less in patients identified by urinary glucose testing but indicate that with combined autoantibody testing 90% of patients can be identified independent of the mode of diagnosis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479394     DOI: 10.1006/jaut.1999.0315

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

Review 1.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

2.  Type 1 diabetes and interferon therapy: a nationwide survey in Japan.

Authors:  Kan Nakamura; Eiji Kawasaki; Akihisa Imagawa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Tetsuro Kobayashi; Akira Shimada; Koji Nakanishi; Hideichi Makino; Taro Maruyama; Toshiaki Hanafusa
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

3.  Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.

Authors:  Eiji Kawasaki; Taro Maruyama; Akihisa Imagawa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Yumiko Kawabata; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Kazuma Takahashi; Masao Nagata; Hideichi Makino; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2013-08-13       Impact factor: 4.232

4.  Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.

Authors:  Junichi Yasui; Eiji Kawasaki; Shoichiro Tanaka; Takuya Awata; Hiroshi Ikegami; Akihisa Imagawa; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Kazuki Yasuda; Hisafumi Yasuda; Toshiaki Hanafusa; Tetsuro Kobayashi
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

5.  Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.

Authors:  Eiji Kawasaki; Akira Okada; Aira Uchida; Takahiro Fukuyama; Yoko Sagara; Yuko Nakano; Hidekazu Tamai; Masayuki Tojikubo; Nobuhiko Koga
Journal:  J Diabetes Investig       Date:  2019-01-25       Impact factor: 4.232

6.  Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.

Authors:  Eiji Kawasaki; Yoichi Oikawa; Akira Okada; Norio Kanatsuna; Tomoyuki Kawamura; Tadashi Kikuchi; Jungo Terasaki; Junnosuke Miura; Yoshihisa Itoh; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2020-08-26       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.